Cadence Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $6.51M | Sell |
261,420
-27,740
| -10% | -$700K | 0.38% | 58 |
|
|
2025
Q3 | $7.37M | Sell |
289,160
-643
| -0.2% | -$15.9K | 0.45% | 50 |
|
|
2025
Q2 | $7.02M | Buy |
289,803
+30,632
| +12% | +$714K | 0.46% | 50 |
|
|
2025
Q1 | $6.57M | Buy |
259,171
+290
| +0.1% | +$7.59K | 0.47% | 49 |
|
|
2024
Q4 | $6.87M | Sell |
258,881
-70,812
| -21% | -$1.92M | 0.47% | 44 |
|
|
2024
Q3 | $9.54M | Buy |
329,693
+54,490
| +20% | +$1.59M | 0.66% | 34 |
|
|
2024
Q2 | $7.7M | Buy |
275,203
+5,079
| +2% | +$140K | 0.58% | 37 |
|
|
2024
Q1 | $7.5M | Sell |
270,124
-18,891
| -7% | -$524K | 0.55% | 42 |
|
|
2023
Q4 | $8.32M | Buy |
289,015
+203,084
| +236% | +$6.14M | 0.68% | 35 |
|
|
2023
Q3 | $2.85M | Sell |
85,931
-6,792
| -7% | -$240K | 0.25% | 81 |
|
|
2023
Q2 | $3.4M | Sell |
92,723
-2,490
| -3% | -$96.9K | 0.3% | 73 |
|
|
2023
Q1 | $3.88M | Buy |
95,213
+2,583
| +3% | +$112K | 0.36% | 67 |
|
|
2022
Q4 | $4.75M | Sell |
92,630
-558
| -0.6% | -$26.8K | 0.44% | 54 |
|
|
2022
Q3 | $4.08M | Buy |
93,188
+75,415
| +424% | +$3.66M | 0.42% | 60 |
|
|
2022
Q2 | $932K | Sell |
17,773
-933
| -5% | -$47.5K | 0.13% | 85 |
|
|
2022
Q1 | $968K | Sell |
18,706
-830
| -4% | -$43.1K | 0.12% | 93 |
|
|
2021
Q4 | $1.15M | Sell |
19,536
-2,210
| -10% | -$109K | 0.14% | 88 |
|
|
2021
Q3 | $935K | Sell |
21,746
-1,030
| -5% | -$45.6K | 0.13% | 94 |
|
|
2021
Q2 | $892K | Buy |
22,776
+330
| +1% | +$12.8K | 0.13% | 96 |
|
|
2021
Q1 | $813K | Sell |
22,446
-153,514
| -87% | -$5.45M | 0.12% | 104 |
|
|
2020
Q4 | $6.48M | Buy |
175,960
+9,133
| +5% | +$335K | 1.02% | 26 |
|
|
2020
Q3 | $5.81M | Sell |
166,827
-4,149
| -2% | -$145K | 1.14% | 21 |
|
|
2020
Q2 | $5.3M | Buy |
170,976
+1,834
| +1% | +$62.3K | 1.09% | 23 |
|
|
2020
Q1 | $5.24M | Buy |
169,142
+38,021
| +29% | +$1.3M | 1.32% | 18 |
|
|
2019
Q4 | $4.87M | Buy |
131,121
+11,449
| +10% | +$408K | 0.9% | 27 |
|
|
2019
Q3 | $4.08M | Buy |
119,672
+6,448
| +6% | +$234K | 0.38% | 47 |
|
|
2019
Q2 | $4.65M | Buy |
113,224
+7,300
| +7% | +$290K | 0.45% | 38 |
|
|
2019
Q1 | $4.27M | Buy |
105,924
+2,230
| +2% | +$89.3K | 0.43% | 36 |
|
|
2018
Q4 | $4.29M | Buy |
103,694
+8,797
| +9% | +$365K | 0.51% | 28 |
|
|
2018
Q3 | $3.97M | Buy |
94,897
+1,734
| +2% | +$66.8K | 0.37% | 36 |
|
|
2018
Q2 | $3.21M | Buy |
93,163
+1,627
| +2% | +$55.6K | 0.29% | 51 |
|
|
2018
Q1 | $3.08M | Buy |
91,536
+2,321
| +3% | +$79.8K | 0.3% | 51 |
|
|
2017
Q4 | $3.07M | Buy |
+89,215
| New | +$3.04M | 0.29% | 48 |
|
Other funds holding PFE
Cadence Bank's PFE Position: Q4 2025 in Review
Cadence Bank reduced its Pfizer (PFE) stake by 9.6% in Q4 2025, selling an estimated $700K and leaving 261,420 shares worth $6.51M. The position accounts for 0.38% of the portfolio, ranked #58.
Cadence Bank first reported a position in PFE in Q4 2017 and has held it in 33 quarters since. The position peaked at $9.54M in Q3 2024. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Cadence Bank held 261,420 shares of Pfizer worth $6.51M as of Q4 2025.
- Cadence Bank sold 27,740 Pfizer shares in Q4 2025, an estimated $700K.
- Pfizer made up 0.38% of Cadence Bank's portfolio in Q4 2025, its #58 holding.
- Cadence Bank first reported a position in Pfizer in Q4 2017 and has held it in 33 quarters since.
- Cadence Bank's Pfizer position peaked at $9.54M in Q3 2024.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Cadence Bank's 13F filing for Q4 2025, filed 30 Jan 2026.